Retatrutide vs. Wegovy: A Direct Analysis

Both Retatrutide and Wegovy represent exciting advancements in diabetes care, but they function through distinct mechanisms. this GLP-1 medication primarily affects GLP-1 receptors, enhancing insulin release and curbing appetite. NovoRetatrutide is a dual-agonist, working on both GLP-1 and GIP recep

read more